Press Release February 23, 2010
Eurofins AvTech Laboratories Adds Michael D. Barron to Team

(February 23, 2010; Portage, MI) – Eurofins AvTech Laboratories, a leading analytical contract research organization (CRO), is pleased to announce the addition of Michael D. Barron, MBA, to Eurofins AvTech.

Barron has been appointed director of business development at Eurofins AvTech. He will be responsible for developing contacts and building relationships with prospective and current clients – and for implementing strategies that will generate revenue growth.

Graduating from The Evergreen State College, located in Olympia, Washington, Barron earned a Bachelor of Science in life sciences. He also received a Master of Business Administration (MBA) from the University of North Carolina at Wilmington.

Barron’s previous positions have contributed to the structure of his significant industry experience, including those held at Catalent Pharma Solutions, Cardinal Health, and other leading contract drug development and analytical service companies. Additionally, Barron has been invited to speak at many industry conferences including American Association of Pharmaceutical Scientists (AAPS), Center for Business Intelligence (CBI), and IBC Life Sciences. He has also been selected to speak at internal strategic planning and educational events for large pharmaceutical companies.

“Michael is an experienced business development professional; we are excited he is part of the Eurofins AvTech team,” stated Eurofins AvTech President, Ray Farmen. “He has a strong network of contacts in the biopharmaceutical industry and a thorough understanding of the drug development process. Michael’s addition marks commitment to our clients and demonstrates our ability to attract high caliber individuals.”

About Eurofins AvTech Laboratories
Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates to stability and release testing of the finished product. Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods.